Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

VEGFR2/CD309 Antikörper (AA 20-125)

Name: VEGFR2/CD309 Antikörper (AA 20-125)
Brand: antibodies-online
SKU: ABIN6254233
Price: 536.12 EUR
Availability: InStock

VEGFR2 Reaktivität: Human, Maus, Ratte, Schwein, Kaninchen, Hund, Affe, Schaf, Pferd, Rind (Kuh), Avian, Cat, Huhn, Esel, Ziege, Meerschweinchen, Hamster WB, IF Wirt: Ziege Polyclonal unconjugated

Anti-VEGFR2 antibody at 1/500 dlution, rabbit palyclonal to goat lgG (HRP), at 1/10,000 dilution, (VEGFR2/CD309 Antikörper (AA 20-125))

1 image

Produktnummer ABIN6254233

Datenblatt (PDF)

Target Alle VEGFR2/CD309 (VEGFR2) Antikörper anzeigen

VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
Bindungsspezifität
37

36

27

22

20

16

16

15

14

10

10

8

8

6

6

6

5

5

5

4

4

3

3

3

3

3

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
AA 20-125

Reaktivität

Human, Maus, Ratte, Schwein, Kaninchen, Hund, Affe, Schaf, Pferd, Rind (Kuh), Avian, Cat, Huhn, Esel, Ziege, Meerschweinchen, Hamster
Wirt
303

55

18

1

1

1

1
Ziege
Passende Sekundärantikörper
Klonalität
297

83
Polyklonal
Konjugat
165

34

20

14

14

13

13

12

11

11

11

11

6

6

6

6

6

3

2

2

2

2

2

1

1

1

1

1

1

1

1
Dieser VEGFR2/CD309 Antikörper ist unkonjugiert
Applikation
234

132

96

87

58

34

26

24

24

14

13

12

9

7

7

4

3

2

2

2

2

1

1

1

1
Western Blotting (WB), Immunofluorescence (IF)

Spezifität

This antibody reacts with a 180 kDa protein and detects endogenous levels of total VEGFR2 protein.

Produktmerkmale

Kinase insert receptor (a type III receptor tyrosine kinase)

Aufreinigung

epitope affinity purified

Immunogen

Purified recombinant peptide derived from the N-terminus (residues 20-125 aa) of human VEGFR2 produced in E. coli.

Isotyp

IgG

Top Product

Discover our top product VEGFR2 Primärantikörper
anti-VEGF Receptor 2 (VEGFR2) (AA 20-200) antibody
VEGFR2 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356), (C-Term) antibody
VEGFR2 Reaktivität: Human WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB01536 unconjugated

anti-VEGF Receptor 2 (VEGFR2) (pTyr951) antibody
VEGFR2 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 20-242) antibody
VEGFR2 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356) antibody
VEGFR2 Reaktivität: Human WB, IHC, ELISA, IF, FACS Wirt: Kaninchen Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 101-200) antibody
VEGFR2 Reaktivität: Human, Maus, Ratte, Kaninchen ELISA, FACS, IHC (p), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 20-764) antibody
VEGFR2 Reaktivität: Human WB, ELISA, FACS, ICC Wirt: Maus Monoclonal 4B4 unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 1225-1356) antibody
VEGFR2 Reaktivität: Human WB, IHC, ELISA, FACS, ICC, Neut Wirt: Maus Monoclonal 1A9A3 unconjugated

anti-VEGF Receptor 2 (VEGFR2) (pTyr1214) antibody
VEGFR2 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 454-469), (Middle Region) antibody
VEGFR2 Reaktivität: Human WB, IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated

Applikationshinweise

Optimal working dilution should be determined by the investigator.

Beschränkungen

Nur für Forschungszwecke einsetzbar
Handhabung

The antibody solution should be gently mixed before use.

Lagerung

4 °C,-20 °C

Informationen zur Lagerung

For continuous use, store at 2-8 deg,C for one-two days. For extended storage, store in -20 deg,C freezer. Working dilution samples should be discarded if not used within 12 hours.
Target

VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Andere Bezeichnung

VEGFR2 (VEGFR2 Produkte)

Synonyme

CD309 antikoerper, FLK1 antikoerper, VEGFR antikoerper, VEGFR2 antikoerper, 6130401C07 antikoerper, Flk-1 antikoerper, Flk1 antikoerper, Krd-1 antikoerper, Ly73 antikoerper, VEGFR-2 antikoerper, sVEGFR-2 antikoerper, Vegfr-2 antikoerper, FLK-1 antikoerper, flk-1 antikoerper, vegfr-2 antikoerper, KDR antikoerper, FLK/KDR antikoerper, flk1 antikoerper, flk1b antikoerper, kdrb antikoerper, si:busm1-205d10.1 antikoerper, si:ch211-254j6.1 antikoerper, si:ch211-278f21.4 antikoerper, wu:fc31a09 antikoerper, fk52c05 antikoerper, flk antikoerper, kdr antikoerper, kdra antikoerper, vegfr2 antikoerper, vegfr4 antikoerper, vegr2 antikoerper, wu:fk52c05 antikoerper, kinase insert domain receptor antikoerper, kinase insert domain protein receptor antikoerper, vascular endothelial growth factor receptor kdr-like antikoerper, kinase insert domain receptor (a type III receptor tyrosine kinase) antikoerper, kinase insert domain receptor like antikoerper, KDR antikoerper, Kdr antikoerper, LOC100136647 antikoerper, kdr antikoerper, kdrl antikoerper

Pathways

RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling